deltatrials
Completed OBSERVATIONAL NCT02964208

AMPLATZER™ LAA Occluder Post Approval Study (PAS)

AMPLATZER™ LAA Occluder Post Approval Study

Sponsor: Abbott Medical Devices

Conditions Atrial Fibrillation Stroke Thromboembolism
Interventions AMPLATZER™ LAA Occluder
Updated 19 times since 2017 Last updated: Mar 27, 2024 Started: Dec 8, 2016 Primary completion: Jun 13, 2022 Completion: Aug 10, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Atrial Fibrillation and Stroke, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 19 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Apr 2018 · 15 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshot~Jul 2019 – ~Aug 2020 · 13 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Jul 2023 · 3 months · monthly snapshot~Jul 2023 – ~Apr 2024 · 9 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Apr 2024 — Jul 2024 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  5. Jul 2023 — Apr 2024 [monthly]

    Active Not Recruiting

▶ Show 14 earlier versions

  1. Apr 2023 — Jul 2023 [monthly]

    Active Not Recruiting

  2. Sep 2022 — Apr 2023 [monthly]

    Active Not Recruiting

  3. Apr 2022 — Sep 2022 [monthly]

    Active Not Recruiting

  4. Dec 2021 — Apr 2022 [monthly]

    Active Not Recruiting

  5. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  6. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  7. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  8. Jul 2019 — Aug 2020 [monthly]

    Recruiting

  9. Mar 2019 — Jul 2019 [monthly]

    Recruiting

  10. Feb 2019 — Mar 2019 [monthly]

    Recruiting

  11. Sep 2018 — Feb 2019 [monthly]

    Recruiting

  12. Jun 2018 — Sep 2018 [monthly]

    Recruiting

  13. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  14. Jan 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott Medical Devices
Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bad Berka, Germany , Bad Segeberg, Germany , Barcelona, Spain , Bonn, Germany , Frankfurt am Main, Germany , Lodelinsart, Belgium , Majadahonda, Spain , Montreal, Canada , Napoli, Italy , New Westminster, Canada and 9 more locations